Search
Showing results for "1"
News & Events
JRDF One WalkPatients, families and our centre staff members took part in JDRF's One Walk last October to raise funds for type 1 diabetes research.
News & Events
School excursions at The Kids Research Institute AustraliaHey teachers and educators - the The Kids Discovery Centre schools pilot program is returning in 2021!
The Scientific Advisory Committee's (SAC) role is to provide scientific direction and to ensure the objectives of WAERP are reflected in the research performed; SAC forms part of our governance structure.
Research
A core outcome set to assess chronic pain interference and impact on emotional functioning for children and young people with cerebral palsyAim: To: (1) develop a core outcome set (COS) to assess chronic pain interference and impact on emotional functioning for children and young people with cerebral palsy (CP) with varying communication, cognitive, and functional abilities; (2) categorize the assessment tools according to reporting method or observer-reported outcome measures; and (3) categorize the content of tools in the COS according to the International Classification of Functioning, Disability and Health (ICF).
News & Events
COVID Update August 2022We have been advised by the Department of Infectious Diseases at Perth Children's Hospital and the Wesfarmers Centre of Vaccines and Infectious Diseases at The Kids Research Institute Australia that COVID-19 vaccinations are now available for young children aged 6 months to 4 years with type 1 diabetes.
News & Events
Kids rock out at diabetes campKids living with Type 1 Diabetes were literally blown away when the Westpac Lifesaver Rescue Helicopter dropped in at the Diabetes WA and PMH kids' camp.
We know many families have questions about the risk of COVID-19 to children with type 1 diabetes. To address these questions, Perth Children’s Hospital’s Diabetes Clinic has provided information and resources to help you navigate this tricky period.
Research
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasiaWe report vaccine efficacy against CIN3+ and adenocarcinoma in situ (AIS) in the end-of-study analysis of PApilloma TRIal against Cancer In young Adults.
Research
Intranasal Insulin Trial IIIf successful, this vaccine could prevent type 1 diabetes and the need for daily insulin injections in people at risk.
An adapted novel flow cytometry methodology to delineate types of cell death in airway epithelial cells Cystic fibrosis (CF) lung disease is